Hamilton Lane Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,350	Closed	-$285K	–	75
2022 Q1	$285K	Hold	7,350	–	–	0.06%	64
2021 Q4	$430K	Sell	7,350 -7,553	-51%	-$442K	0.06%	71
2021 Q3	$883K	Buy	+14,903	New	+$883K	0.15%	55